- Home
- / BioSpecifics Technologies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioSpecifics Technologies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$88.5
2020-12-17
Market Capitalization
$650.2 M
2020-12-17
Revenue
$38.2 M
FY, 2019
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.4M | 11.1M | 14.5M | 14.1M | 22.8M | 26.3M | 27.4M | 33.0M | 38.2M |
| Revenue growth, % | 15.4% | ||||||||
| General and administrative expense | 5.2M | 4.8M | 5.0M | 5.8M | 7.3M | 7.9M | 8.5M | 8.8M | 9.3M |
| Operating expense total | 6.2M | 6.0M | 6.5M | 7.1M | 8.3M | 9.2M | 9.8M | 9.6M | 9.9M |
| EBIT | 5.2M | 5.1M | 7.9M | 7.0M | 14.4M | 17.0M | 17.7M | 23.4M | 28.3M |
| EBIT margin, % | 45.6% | 45.9% | 54.9% | 49.7% | 63.5% | 64.9% | 64.4% | 71.0% | 74.1% |
| Interest income | 55.8K | 34.6K | 26.2K | 32.2K | 92.9K | 295.8K | 636.6K | 1.3M | 2.0M |
| Interest expense | 107.6K | 348.6K | 687.6K | 1.4M | |||||
| Pre tax profit | 5.3M | 5.2M | 8.0M | 7.0M | 14.6M | 17.4M | 18.4M | 24.8M | 30.3M |
| Income tax expense | (1.3M) | 2.2M | 2.7M | 2.4M | 4.9M | 6.0M | 7.0M | 4.7M | 5.8M |
| Net Income | 6.6M | 3.0M | 5.3M | 4.6M | 9.6M | 11.4M | 11.3M | 20.1M | 24.5M |